Search Results - "Linhares, Flávia P"

Recombinant endonuclease III protein from Leishmania infantum associated with Th1-type adjuvants is immunogenic and induces protection against visceral leishmaniasis by Lage, Daniela P., Machado, Amanda S., Freitas, Camila S., Vale, Danniele L., Linhares, Flávia P., Cardoso, Jamille M.O., Oliveira-da-Silva, João A., Ramos, Fernanda F., Pereira, Isabela A.G., Ludolf, Fernanda, Tavares, Grasiele S.V., Bandeira, Raquel S., Oliveira, Jamil S., Menezes-Souza, Daniel, Duarte, Mariana C., Galdino, Alexsandro S., Christodoulides, Myron, Chávez-Fumagalli, Miguel A., Roatt, Bruno M., Martins, Vívian T., Coelho, Eduardo A.F.

“…Vaccination against visceral leishmaniasis (VL) should be considered as a safe and effective measure to disease control; however, few vaccines are available…”
Get full text

Recombinant guanosine-5′-triphosphate (GTP)-binding protein associated with Poloxamer 407-based polymeric micelles protects against Leishmania infantum infection by Lage, Daniela P., Machado, Amanda S., Vale, Danniele L., Freitas, Camila S., Linhares, Flávia P., Cardoso, Jamille M.O., Pereira, Isabela A.G., Ramos, Fernanda F., Tavares, Grasiele S.V., Ludolf, Fernanda, Oliveira-da-Silva, João A., Bandeira, Raquel S., Silva, Alessandra M., Simões, Luciana C., Reis, Thiago A.R., Oliveira, Jamil S., Christodoulides, Myron, Chávez-Fumagalli, Miguel A., Roatt, Bruno M., Martins, Vívian T., Coelho, Eduardo A.F.

“…[Display omitted] •A GTP-binding protein was used as recombinant antigen against L. infantum.•It was associated with saponin or in polymeric micelles as…”
Get full text

Leishmania LiHyC protein is immunogenic and induces protection against visceral leishmaniasis by Machado, Amanda S., Lage, Daniela P., Vale, Danniele L., Freitas, Camila S., Linhares, Flávia P., Cardoso, Jamille M. O., Oliveira‐da‐Silva, João A., Pereira, Isabela A. G., Ramos, Fernanda F., Tavares, Grasiele S. V., Ludolf, Fernanda, Bandeira, Raquel S., Maia, Luiz G. N., Menezes‐Souza, Daniel, Duarte, Mariana C., Chávez‐Fumagalli, Miguel A., Roatt, Bruno M., Christodoulides, Myron, Martins, Vívian T., Coelho, Eduardo Antonio Ferraz

“…Treatment against visceral leishmaniasis (VL) presents problems by the toxicity of drugs, high cost and/or emergence of resistant strains. The diagnosis is…”
Get full text

A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum Infection by Lage, Daniela P, Vale, Danniele L, Linhares, Flávia P, Freitas, Camila S, Machado, Amanda S, Cardoso, Jamille M O, de Oliveira, Daysiane, Galvani, Nathália C, de Oliveira, Marcelo P, Oliveira-da-Silva, João A, Ramos, Fernanda F, Tavares, Grasiele S V, Ludolf, Fernanda, Bandeira, Raquel S, Pereira, Isabela A G, Chávez-Fumagalli, Miguel A, Roatt, Bruno M, Machado-de-Ávila, Ricardo A, Christodoulides, Myron, Coelho, Eduardo A F, Martins, Vívian T

“…Currently, there is no licensed vaccine to protect against human visceral leishmaniasis (VL), a potentially fatal disease caused by infection with Leishmania…”
Get full text

A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantum by Machado, Amanda S., Lage, Daniela P., Vale, Danniele L., Freitas, Camila S., Linhares, Flávia P., Cardoso, Jamille M.O., Pereira, Isabela A.G., Ramos, Fernanda F., Tavares, Grasiele S.V., Ludolf, Fernanda, Oliveira-da-Silva, João A., Bandeira, Raquel S., Simões, Aratti C., Duarte, Mariana C., Oliveira, Jamil S., Christodoulides, Myron, Chávez-Fumagalli, Miguel A., Roatt, Bruno M., Martins, Vívian T., Coelho, Eduardo A.F.

“…•A new leishmania amastigote protein, LiHyG, was evaluated against L. infantum.•It was associated with saponin or poloxamer 407-based polymeric micelles.•Both…”
Get full text